THIS IS THE SUMMARY OF THE COMPANY FURTHER INFORMATION CAN BE FOUND IN THE BUSINESS PLAN UPON REQUEST
Alora Medical is a South African-based Healthcare company that meets global standards to produce and import high-quality medical devices and other medicine at cost-effective prices to serve patients in South and Southern Africa. We aim to be the partner of choice for innovative, best-in-class healthcare solutions by enriching people’s lives using Alora Medical products.
Accepting grants , equity funding , angels and VCs
The respiratory device market has demonstrated resilience and growth potential, particularly in the context of ongoing health challenges. Alora Med's commitment to improving respiratory health aligns with a broader global trend towards preventive healthcare. By supporting Alora Med, investors have the opportunity to contribute to public health while potentially gaining from the anticipated market expansion and the positive impact on patients' lives in Africa.
Reference:Markets and Markets: Attractive opportunities in the respiratory devices care market.
The Global market potential for a respiratory device is significant, driven by several key factors. Firstly, the increasing prevalence of respiratory issues worldwide, accentuated by factors such as pollution and lifestyle changes, highlights the need for effective respiratory solutions. Moreover, the ongoing global health challenges, including respiratory-related issues, have intensified the focus on healthcare infrastructure and the demand for advanced medical devices. As countries, including South Africa, prioritize bolstering their healthcare systems, the market for respiratory devices becomes increasingly relevant. Investing in Alora Med's respiratory device for the South African market not only taps into the local demand but also positions the company to address broader global health trends. The device's potential success in South Africa could serve as a launchpad for expansion into other regions facing similar health challenges, creating a substantial growth trajectory for investors on a global scale. The global respiratory care devices market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028 presenting a vast opportunity for investors
The information has been verified through Companies and intellectual property comission
THIS IS THE VERIFIED COMPANY REGISTRATION NUMBER
KINGFISHER STREET
ROOIHUISKRAAL NOORD
PRETORIA
GAUTENG
This is the most Recent company director listened on CIPC
DAMINDA SENEKAL-GRIESSEL
MAGDA PAPADOPOULOS